BenchSci exponentially increases the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime and Google’s AI fund, Gradient Ventures, BenchSci uses machine learning to diagnose pharmaceutical R&D health from hidden patterns in procurement data.
Customers receive a report on failure rates, productivity, and redundancy by department, therapeutic area, geography, and cost center. They can then address inefficiencies by deploying BenchSci's AI-Assisted Reagent Selection, which empowers scientists to select the best reagents and design criteria for their experiments. Thereafter, post-deployment reports confirm impact and ROI.
Total Funding: $94.8 M
Funding Stage: Series C
Business Stage: Scaling Up
Market: B2B
Company Size: 101 to 250
Founded: 2015
Jan 2021
- BenchSci Listed as Best Workplace? for Startups in Canada for 2nd Consecutive Year
Mar 2019
- Sanbio B.V. Partners with BenchSci to Augment Visibility and Purchasability of Its IHC Antibodies
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at BenchSci
Software Engineer - ML/DevOps
Toronto, Ontario
R&D Engineer
Toronto, Ontario
UX Researcher
Toronto, Ontario
Senior Product Manager
Toronto, Ontario
Director of Product Design
Toronto, Ontario
